Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Europe.
Press releases published on September 5, 2025
electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
GlobeNewswire
·
September 5, 2025
ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
GlobeNewswire
·
September 5, 2025
– 17 abstracts accepted, including one oral presentation – – Data from the REFRESH real-world study highlight efficacy of once-nightly sodium oxybate when switching from twice-nightly oxybates – – REFRESH study also highlights efficacy in those who were …
Geotab atinge 5 milhões de veículos conectados globalmente e reforça liderança em telemática
GlobeNewswire
·
September 5, 2025
SÃO PAULO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- A Geotab anunciou a conquista de um novo marco: alcançou a marca de mais de 5 milhões de veículos conectados globalmente, reforçando sua liderança em telemática e soluções para o setor de transportes. O …
Youxin Technology Ltd Announces Pricing of $6.0 Million Underwritten Public Offering
GlobeNewswire
·
September 5, 2025
GUANGZHOU, CHINA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (NASDAQ: YAAS) (the “Company”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their …
Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America
GlobeNewswire
·
September 5, 2025
KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological …
Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future
GlobeNewswire
·
September 5, 2025
Frankfurt, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Blocksize, a German-based DeFi infrastructure provider, is calling attention to the hidden fees of custodial staking platforms, which quietly erode yields, undermine governance, and place long-term …
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
GlobeNewswire
·
September 5, 2025
EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. …
NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board
GlobeNewswire
·
September 5, 2025
Vancouver, B.C. , Sept. 05, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …
iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June 30, 2025, and provided a corporate update on its progress. …
Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie
GlobeNewswire
·
September 5, 2025
EGRIFTA WRMC offre la commodité d’une reconstitution hebdomadaire et d’un volume d’injection quotidien réduit, comparativement à EGRIFTA SVMD Les pharmacies spécialisées commandent désormais EGRIFTA WRMC pour exécuter les ordonnances MONTRÉAL, 05 sept. …
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
GlobeNewswire
·
September 5, 2025
~ All patients in the first cohort achieved between 27- to 208-fold increases in α-Gal A activity relative to mean normal level ~ ~ All patients in first cohort discontinued enzyme replacement therapy ~ ~ Preliminary data show AMT-191 has a manageable …
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
GlobeNewswire
·
September 5, 2025
-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- -- Announced in advance of World Duchenne Awareness Day on …
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
GlobeNewswire
·
September 5, 2025
- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment - - 90% of 12-month …
Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
TORONTO and HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage cancer immunotherapy company focused on the development of Superkines, announced today that Dr. …
Koryx Copper Announces Planned Continuation to Luxembourg
GlobeNewswire
·
September 5, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Koryx Copper Inc. (the “Company”) (TSX-V: KRY) (NSX: KYX) today announced its intention to …
AAVantgarde presents updated positive clinical data from its AAVB-081 program for Usher 1B at EURetina 2025
GlobeNewswire
·
September 5, 2025
MILAN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced the presentation of updated clinical data from the …
Akari Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
BOSTON and LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced that Abizer Gaslightwala, President and Chief …
Wrap Technologies and STORM Training Group Partner to Deliver Post-BolaWrap® Arrest & Control Training via WrapTactics™
GlobeNewswire
·
September 5, 2025
MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company” or “Wrap”), a leader in pre-escalation and public safety solutions, today announced a strategic partnership with STORM Training Group, a Minnesota-based …